ArticleFrontiers in oncology2026
Physeal breach as a potential predictor of pulmonary metastasis in paediatric osteosarcoma.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteosarcoma (OS) is the most common primary malignant bone tumour in adolescents, and pulmonary metastasis remains the leading cause of death. In skeletally immature patients, the avascular physis is considered a barrier to local tumour spread, but its relationship to lung metastasis has not been quantified. Methods: We conducted a single-centre, retrospective cohort study of 32 paediatric OS patients. Tumour-physis relationships were evaluated before and after chemotherapy using standard local staging and chest CT. The primary outcome was pulmonary metastasis at last follow-up, analysed with multivariable logistic regression including age, sex, tumour size, location, laterality, and physeal breach. A complementary orthotopic tibial xenograft model was established by injecting 143B cells into nude mice, creating physeal-breach and non-breach groups. Vascular endothelial growth factor (VEGF) immunohistochemistry (IHC) assessed angiogenic activity at the tumour-physis interface. Results: Pulmonary metastases were present in 22% at diagnosis and in 50% (16/32) by last follow-up. Physeal breach was the only independent predictor of metastasis (odds ratio 59.89; 95% CI 3.34-1073.95; p=0.006). In the xenograft model, pulmonary metastases developed in all physeal-breach mice and in none of the non-breach group. VEGF IHC showed increased angiogenic activity in breach-associated tumours. Conclusion: Physeal breach identifies a biologically aggressive subset of paediatric OS with high metastatic potential. Because breach status is readily appreciable on routine imaging, it may serve as a practical biomarker to refine risk stratification, predict pulmonary metastasis and guide evaluation of anti-angiogenic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.